Zhudong, Taiwan

Fen-Fei Lin

USPTO Granted Patents = 2 

 

Average Co-Inventor Count = 6.5

ph-index = 1


Location History:

  • Zhudong Township, TW (2018)
  • Hsinchu County, TW (2023)

Company Filing History:


Years Active: 2018-2023

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations in Hematocrit Measurement: The Contributions of Fen-Fei Lin

Introduction: Fen-Fei Lin, an inventive mind based in Zhudong, Taiwan, has made significant contributions to the field of medical testing through his innovative patents. With a focus on improving methods for analyzing blood samples, Lin has garnered recognition for his work in developing technologies that enhance the accuracy and efficiency of hematocrit measurement.

Latest Patents: Fen-Fei Lin holds two patents that showcase his innovative approaches in the medical field. The first patent, titled "Method of Measuring Hematocrit," involves a unique procedure using a test strip equipped with electrodes. This method enables the measurement of hematocrit values from whole blood samples by applying square wave voltages intermittently and calculating feedback to achieve accurate results. The second patent, "Methods for Measuring Analyte Concentration," presents a comprehensive method to detect analyte concentration using a blood sample. This method employs a first and second electrode set, utilizing voltammetry to derive crucial response values and calculate both hematocrit and analyte concentration.

Career Highlights: Fen-Fei Lin is currently affiliated with the Industrial Technology Research Institute, where he applies his expertise in developing advanced measurement techniques. His work is instrumental in pushing the boundaries of medical technology, resulting in unprecedented advancements in blood analysis.

Collaborations: Lin has collaborated with notable colleagues, including Chu-Hsuan Chen and Yu-Fang Yen. Their joint efforts contribute to the innovative research environment at the Industrial Technology Research Institute, fostering a culture of collaboration and excellence in the field of medical technology.

Conclusion: Fen-Fei Lin continues to be a driving force in the development of innovative methods for blood sample analysis. His contributions not only enhance medical testing but also pave the way for future advancements in healthcare diagnostics. As his career progresses, Lin is expected to remain at the forefront of innovation in his field, impacting both scientific research and patient care.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…